We face colliding pressures. MFN is challenging our freedom to operate. JCAs are compressing evidence timelines into months. Technology is changing weekly. Patients and HCPs now speak to AI daily before they ask us.
They land on the same launches, the same evidence and the same customers, and they move faster than any one function can respond. When evidence, customer data and decisions stay divided by function, market and system, we can’t keep up.
But the connection that makes this difficult is also what makes it solvable. Some teams are already showing it: value cases built before launch, not after. AI judged on business impact, not adoption. Pilots that become how the whole field works. None of us have all of the answers, but together we have enough to move far faster than any of us could alone.
We have shared ambition: getting medicines to more patients, sooner. At Pharma 2027, leave Barcelona with clearer choices, stronger connections and practical frameworks to turn that ambition into impact.
See you there.
In today’s digital age, face-to-face relationships are more important than ever. We connect you in person with senior decision-makers, in a setting built for depth: peer groupings, curated networking and closed-door sessions.
Senior pharma leaders, payers, providers and patient representatives meet in a setting built for depth. The calibre of people in the room is one of the event’s strongest draws, and solution providers are a standout. Peer groupings, curated networking and closed-door sessions keep every conversation relevant.
